Overview
Steven Penegar practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Bladder Cancer, Familial Colorectal Cancer, and Non-Muscle Invasive Bladder Cancer.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Steven R. Penegar
Is Steven R. Penegar a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Steven R. Penegar is classified as an Experienced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Steven R. Penegar participate in research or clinical trials?
Yes. Steven R. Penegar has published 15 articles and abstracts on conditions like Bladder Cancer. You can view a list of Steven R. Penegar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerMr. Penegar isExperienced. Learn about Bladder Cancer.
- Familial Colorectal CancerMr. Penegar isExperienced. Learn about Familial Colorectal Cancer.
- Non-Muscle Invasive Bladder CancerMr. Penegar isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.